Organizational Model and Code of Ethics

Pizeta Pharma S.p.A. conducts its business in accordance with the principles of legality, integrity, fairness, transparency, loyalty and efficiency, which represent the core values guiding the Company's organisation and all of its business activities.

As part of its corporate governance and internal control system, the Company has adopted an Organisation, Management and Control Model pursuant to Italian Legislative Decree No. 231/2001 (the "Model"), with the aim of preventing the commission of offences giving rise to the administrative liability of legal entities under the aforementioned Decree and promoting a corporate culture based on legality and business ethics.

The Model forms an integral part of the Company's internal control system and is based, among other things, on the identification of activities exposed to the risk of criminal offences, the definition of principles and rules of conduct, the adoption of specific prevention and control protocols, training and awareness initiatives, a disciplinary system, and the establishment of a Supervisory Body responsible for monitoring its effective implementation and compliance.

The Model was adopted by the Board of Directors of Pizeta Pharma S.p.A. by resolution dated 2 September 2019 and has subsequently been updated in order to reflect changes in the applicable legal framework as well as the Company's organisational and operational developments.

The provisions of the Model are binding upon the Company's directors, employees and, within the scope of their respective activities, all people who, for any reason, act in the name of, on behalf of, or in the interest of the Company.

The Company has also adopted a Code of Ethics, which sets out the values and principles of conduct that must guide everyone who has dealings with the Company. The Code of Ethics defines the principles of fairness, integrity, transparency, responsibility and compliance with applicable laws and regulations that govern the Company's business activities and forms an integral part of the Organisation, Management and Control Model. The Code of Ethics was also approved by the Board of Directors on 2 September 2019 and has subsequently been updated.

Pursuant to Article 6 of Italian Legislative Decree No. 231/2001, the Company has also established a Supervisory Body (Organismo di Vigilanza), vested with independent powers of initiative and control, whose duties include monitoring the effectiveness of and compliance with the Model, as well as promoting its continuous updating.

The effectiveness of the Model depends on the cooperation of all persons to whom it applies, as well as of all parties having dealings with the Company. To this end, directors, employees, collaborators, consultants, suppliers, business partners and any other interested parties may submit reports, information or communications concerning breaches of the Model, the Code of Ethics or the legislation relevant for the purposes of Italian Legislative Decree No. 231/2001 through the following channels:

  • By ordinary mail: Via Bruno Simonucci, No. 3, 06135 Ponte San Giovanni, Perugia (PG), Italy
  • By e-mail: odv@pizetapharma.com
  • Through the whistleblowing platform: https://pizetapharma.segnalazioni.net/

DOWNLOAD
Index
Code of Ethics